KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Current Deferred Revenue (2016 - 2025)

Labcorp Holdings' Current Deferred Revenue history spans 11 years, with the latest figure at $439.1 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 11.96% year-over-year to $439.1 million; the TTM value through Dec 2025 reached $439.1 million, up 11.96%, while the annual FY2025 figure was $439.1 million, 11.96% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $439.1 million at Labcorp Holdings, up from $391.6 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $593.9 million in Q3 2021 and bottomed at $310.6 million in Q4 2022.
  • The 5-year median for Current Deferred Revenue is $412.4 million (2023), against an average of $453.9 million.
  • The largest annual shift saw Current Deferred Revenue tumbled 44.39% in 2022 before it skyrocketed 35.77% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $558.5 million in 2021, then crashed by 44.39% to $310.6 million in 2022, then surged by 35.77% to $421.7 million in 2023, then fell by 7.0% to $392.2 million in 2024, then rose by 11.96% to $439.1 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Current Deferred Revenue are $439.1 million (Q4 2025), $391.6 million (Q3 2025), and $398.0 million (Q2 2025).